Tag: ERSPC
EAU17: Prostate Cancer Prevention Group tackles limits of active surveillance
The question of which of prostate cancer (PCa) patients are suitable for active surveillance (AS) remains a complex issue, and experts yesterday cautioned that doctors should exercise due restraint to avoid over-treatment. The special session organized by the Prostate...
EMUC16: National cancer prevention plans need a boost
National cancer plans, which are vital for an effective pan-European cancer care programme, should look closer at prevention, rehabilitation and survivorship issues, according to a public healthcare expert who spoke at the 8th European Multidisciplinary Meeting on Urological Cancers...
EMUC15: Study shows prostate cancer screening under age of 55 may be of limited value
Barcelona, 14 November 2015 – Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after the age of 55, according to a new 20 year analysis of 6822 patients, presented...
Plenary Session 5: Update and controversies in prostate cancer
“The 29th EAU Congress has been a success. Particularly the attendance of countries beyond Europe was very high, for example Latin American countries like Brazil and Venezuela,” said Prof. Per-Anders Abrahamsson (Malmö, SE) in his opening remarks during the...
Prostate Cancer Risk Calculator offers men ‘individual risk assessment’
Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, launched yesterday, 17 May 2012, has been created by the founders of the European Randomized...